Home
Scholarly Works
Adalimumab versus Infliximab for the Treatment of...
Conference

Adalimumab versus Infliximab for the Treatment of Moderate-to-severe Ulcerative Colitis in Adult Patients with No Prior Anti-TNF Experience: An Indirect Comparison Meta-analysis

Authors

Thorlund K; Druyts E; Mills E; Fedorak R; Marshal J

Volume

108

Publisher

Wolters Kluwer

Publication Date

October 1, 2013

DOI

10.14309/00000434-201310001-01802

Conference proceedings

The American Journal of Gastroenterology

ISSN

0002-9270
View published work (Non-McMaster Users)

Contact the Experts team